SEC Form 4 · accession 0001209191-17-065524
ADURO BIOTECH, INC. · ADRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen T Isaacs
Officer — President and CEO · Director
Period of report
Dec 11, 2017
Accepted (ET)
Dec 13, 2017 · 8:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001435049
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 11, 2017 | A | 44,200 | $0.00 | A | 218,121 | D | |
| Common StockF2 | holding | — | — | — | 70,657 | I | By Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents grant of restricted stock units payable in common stock that vest in four equal annual installments from the grant date of December 11, 2017.
- F2The shares are owned directly by the Isaacs-MacBride Family Trust UAD 03/09/01, for which the Reporting Person is a trustee.